• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

荷兰接种疫苗50年后对白喉的长期保护:一项血清流行病学研究的结果

Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study.

作者信息

Swart E M, van Gageldonk P G M, de Melker H E, van der Klis F R, Berbers G A M, Mollema L

机构信息

Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.

出版信息

PLoS One. 2016 Feb 10;11(2):e0148605. doi: 10.1371/journal.pone.0148605. eCollection 2016.

DOI:10.1371/journal.pone.0148605
PMID:26863307
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4749226/
Abstract

BACKGROUND AND AIMS

To evaluate the National Immunisation Programme (NIP) a population-based cross-sectional seroepidemiological study was performed in the Netherlands. We assessed diphtheria antitoxin levels in the general Dutch population and in low vaccination coverage (LVC) areas where a relatively high proportion of orthodox Protestants live who decline vaccination based on religious grounds. Results were compared with a nationwide seroepidemiological study performed 11 years earlier.

METHODS

In 2006/2007 a national serum bank was established. Blood samples were tested for diphtheria antitoxin IgG concentrations using a multiplex immunoassay for 6383 participants from the national sample (NS) and 1518 participants from LVC municipalities. A cut-off above 0.01 international units per ml (IU/ml) was used as minimum protective level.

RESULTS

In the NS 91% of the population had antibody levels above 0.01 IU/ml compared to 88% in the 1995/1996 serosurvey (p<0.05). On average, 82% (vs. 78% in the 1995/1996 serosurvey, p<0.05) of individuals from the NS born before introduction of diphtheria vaccination in the NIP and 46% (vs. 37% in the 1995/1996 serosurvey, p = 0.11) of orthodox Protestants living in LVC areas had antibody levels above 0.01 IU/ml. Linear regression analysis among fully immunized individuals (six vaccinations) without evidence of revaccination indicated a continuous decline in antibodies in both serosurveys, but geometric mean antibodies remained well above 0.01 IU/ml in all age groups.

CONCLUSIONS

The NIP provides long-term protection against diphtheria, although antibody levels decline after vaccination. As a result of natural waning immunity, a substantial proportion of individuals born before introduction of diphtheria vaccination in the NIP lack adequate levels of diphtheria antibodies. Susceptibility due to lack of vaccination is highest among strictly orthodox Protestants. The potential risk of spread of diphtheria within the geographically clustered orthodox Protestant community after introduction in the Netherlands has not disappeared, despite national long-term high vaccination coverage.

摘要

背景与目的

为评估国家免疫规划(NIP),在荷兰开展了一项基于人群的横断面血清流行病学研究。我们评估了荷兰普通人群以及低疫苗接种覆盖率(LVC)地区的白喉抗毒素水平,在这些地区居住着相对较高比例基于宗教原因拒绝接种疫苗的东正教新教徒。将结果与11年前进行的一项全国血清流行病学研究进行了比较。

方法

2006/2007年建立了一个国家血清库。使用多重免疫测定法检测了来自全国样本(NS)的6383名参与者和来自LVC市的1518名参与者的血样中的白喉抗毒素IgG浓度。每毫升高于0.01国际单位(IU/ml)的临界值被用作最低保护水平。

结果

在全国样本中,91%的人群抗体水平高于0.01 IU/ml,而在1995/1996年血清学调查中这一比例为88%(p<0.05)。平均而言,在国家免疫规划中白喉疫苗接种引入之前出生的全国样本个体中,82%(1995/1996年血清学调查中为78%,p<0.05)以及居住在LVC地区的东正教新教徒中有46%(1995/1996年血清学调查中为37%,p = 0.11)的抗体水平高于0.01 IU/ml。在没有再次接种证据的完全免疫个体(接种六次)中进行的线性回归分析表明,在两次血清学调查中抗体水平均持续下降,但所有年龄组的几何平均抗体水平仍远高于0.01 IU/ml。

结论

国家免疫规划提供了对白喉的长期保护,尽管接种疫苗后抗体水平会下降。由于自然免疫力减弱,在国家免疫规划中白喉疫苗接种引入之前出生的相当一部分个体缺乏足够水平的白喉抗体。在严格的东正教新教徒中,因未接种疫苗导致的易感性最高。尽管荷兰全国长期保持高疫苗接种覆盖率,但在荷兰引入白喉后,白喉在地理上聚集的东正教新教社区内传播的潜在风险并未消除。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397c/4749226/19414dfa292a/pone.0148605.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397c/4749226/1c97345c7b1e/pone.0148605.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397c/4749226/75817a0483c0/pone.0148605.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397c/4749226/19414dfa292a/pone.0148605.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397c/4749226/1c97345c7b1e/pone.0148605.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397c/4749226/75817a0483c0/pone.0148605.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/397c/4749226/19414dfa292a/pone.0148605.g003.jpg

相似文献

1
Long-Term Protection against Diphtheria in the Netherlands after 50 Years of Vaccination: Results from a Seroepidemiological Study.荷兰接种疫苗50年后对白喉的长期保护:一项血清流行病学研究的结果
PLoS One. 2016 Feb 10;11(2):e0148605. doi: 10.1371/journal.pone.0148605. eCollection 2016.
2
Diphtheria antitoxin levels in the Netherlands: a population-based study.荷兰白喉抗毒素水平:一项基于人群的研究。
Emerg Infect Dis. 1999 Sep-Oct;5(5):694-700. doi: 10.3201/eid0505.990511.
3
Investigation of immunity level against diphtheria and reinforcement of immunity by booster vaccination for infection control staff in Okayama prefecture.冈山县感染控制工作人员对白喉的免疫水平调查及通过加强免疫接种强化免疫
Jpn J Infect Dis. 2008 Mar;61(2):104-6.
4
Report: seroprevalence of corynebacterium diphtheriae among vaccinated population of Rawalpindi/Islamabad, Pakistan.报告:巴基斯坦拉瓦尔品第/伊斯兰堡接种疫苗人群中白喉棒状杆菌的血清阳性率。
Pak J Pharm Sci. 2013 May;26(3):649-51.
5
Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland.波兰儿童、青少年及成人中白喉类毒素IgG抗体的血清阳性率。
BMC Infect Dis. 2013 Nov 19;13:551. doi: 10.1186/1471-2334-13-551.
6
Seroprevalence of diphtheria toxoid IgG antibodies in the Malaysian population.马来西亚人群中白喉类毒素 IgG 抗体的血清阳性率。
BMC Infect Dis. 2021 Jun 16;21(1):581. doi: 10.1186/s12879-021-06285-3.
7
Determination of neutralizing antibodies and specific immunoglobulin isotype levels in infants after vaccination against diphtheria.
Eur J Clin Microbiol Infect Dis. 1992 Apr;11(4):341-5. doi: 10.1007/BF01962074.
8
Immunity against diphtheria among children and adults in Izmir, Turkey.土耳其伊兹密尔市儿童和成人对白喉的免疫力。
Vaccine. 2011 Jun 10;29(26):4341-4. doi: 10.1016/j.vaccine.2011.04.016. Epub 2011 Apr 19.
9
Diphtheria in Lao PDR: Insufficient Coverage or Ineffective Vaccine?老挝人民民主共和国的白喉:是覆盖率不足还是疫苗无效?
PLoS One. 2015 Apr 24;10(4):e0121749. doi: 10.1371/journal.pone.0121749. eCollection 2015.
10
[Diphtheria immunity in school beginners and after reimmunization with d-vaccine].[学校新生及再次接种白喉-破伤风疫苗后的白喉免疫力]
Dtsch Med Wochenschr. 1992 Aug 28;117(35):1308-12. doi: 10.1055/s-2008-1062444.

引用本文的文献

1
Mapping anti-diphtheria toxin antibody: a systematic review and meta-analysis with multi-level meta-regression.抗白喉毒素抗体图谱:一项采用多层次Meta回归的系统评价与Meta分析
Pathog Glob Health. 2025 Feb-Mar;119(1-2):48-59. doi: 10.1080/20477724.2024.2434773. Epub 2024 Dec 9.
2
A literature review and evidence-based evaluation of the Dutch national immunisation schedule yield possibilities for improvements.一项关于荷兰国家免疫规划的文献综述及基于证据的评估揭示了改进的可能性。
Vaccine X. 2024 Sep 26;20:100556. doi: 10.1016/j.jvacx.2024.100556. eCollection 2024 Oct.
3
High-resolution African HLA resource uncovers HLA-DRB1 expression effects underlying vaccine response.

本文引用的文献

1
Access to diphtheria antitoxin for therapy and diagnostics.获得白喉抗毒素用于治疗和诊断。
Euro Surveill. 2014 Jun 19;19(24):20830. doi: 10.2807/1560-7917.es2014.19.24.20830.
2
Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland.波兰儿童、青少年及成人中白喉类毒素IgG抗体的血清阳性率。
BMC Infect Dis. 2013 Nov 19;13:551. doi: 10.1186/1471-2334-13-551.
3
Immunogenicity of 13-valent pneumococcal conjugate vaccine administered according to 4 different primary immunization schedules in infants: a randomized clinical trial.
高分辨率非洲 HLA 资源揭示了疫苗反应背后的 HLA-DRB1 表达效应。
Nat Med. 2024 May;30(5):1384-1394. doi: 10.1038/s41591-024-02944-5. Epub 2024 May 13.
4
Surveillance of diphtheria in the Netherlands between 2000-2021: cutaneous diphtheria supersedes the respiratory form.荷兰 2000-2021 年白喉监测:皮肤型白喉取代了呼吸道型。
BMC Infect Dis. 2023 Jun 21;23(1):420. doi: 10.1186/s12879-023-08388-5.
5
High-Throughput IgG Epitope Mapping of Tetanus Neurotoxin: Implications for Immunotherapy and Vaccine Design.高通量 IgG 破伤风神经毒素表位作图:对免疫治疗和疫苗设计的意义。
Toxins (Basel). 2023 Mar 24;15(4):239. doi: 10.3390/toxins15040239.
6
Genetic characterization of diphtheria B to evaluate vaccine efficacy in Indonesia.对印度尼西亚白喉B进行基因特征分析以评估疫苗效力。
Iran J Microbiol. 2022 Aug;14(4):606-610. doi: 10.18502/ijm.v14i4.10248.
7
Building an integrated serosurveillance platform to inform public health interventions: Insights from an experts' meeting on serum biomarkers.建立一个综合的血清学监测平台,为公共卫生干预措施提供信息:血清生物标志物专家会议的见解。
PLoS Negl Trop Dis. 2022 Oct 6;16(10):e0010657. doi: 10.1371/journal.pntd.0010657. eCollection 2022 Oct.
8
Waning rate of immunity and duration of protective immunity against diphtheria toxoid as a function of age and number of doses: Systematic review and quantitative data analysis.免疫效价下降率和对白喉类毒素的保护免疫持续时间随年龄和剂量数的变化:系统评价和定量数据分析。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2099700. doi: 10.1080/21645515.2022.2099700. Epub 2022 Jul 21.
9
Diphtheria in the WHO European Region, 2010 to 2019.2010 年至 2019 年世卫组织欧洲区域白喉疫情。
Euro Surveill. 2022 Feb;27(8). doi: 10.2807/1560-7917.ES.2022.27.8.2100058.
10
Validation of a diphtheria toxoid multiplex bead assay for serosurveys.验证一种白喉类毒素多重微球检测试剂盒在血清学调查中的应用。
Diagn Microbiol Infect Dis. 2021 Jul;100(3):115371. doi: 10.1016/j.diagmicrobio.2021.115371. Epub 2021 Mar 13.
根据 4 种不同的基础免疫方案在婴儿中接种 13 价肺炎球菌结合疫苗的免疫原性:一项随机临床试验。
JAMA. 2013 Sep 4;310(9):930-7. doi: 10.1001/jama.2013.228052.
4
Immunity to tetanus and diphtheria in the UK in 2009.2009 年英国破伤风和白喉的免疫情况。
Vaccine. 2012 Nov 19;30(49):7111-7. doi: 10.1016/j.vaccine.2012.09.029. Epub 2012 Sep 26.
5
Comparative seroepidemiology of diphtheria in six European countries and Israel.六个欧洲国家和以色列白喉血清流行病学比较。
Epidemiol Infect. 2013 Jan;141(1):132-42. doi: 10.1017/S0950268812000210. Epub 2012 Feb 24.
6
Measuring vaccination coverage in a hard to reach minority.测量难以接触到的少数民族的疫苗接种率。
Eur J Public Health. 2012 Jun;22(3):359-64. doi: 10.1093/eurpub/ckr081. Epub 2011 Jun 29.
7
Improved specificity of a multiplex immunoassay for quantitation of anti-diphtheria toxin antibodies with the use of diphtheria toxoid.使用白喉类毒素提高多重免疫测定法检测抗白喉毒素抗体定量的特异性。
Clin Vaccine Immunol. 2011 Jul;18(7):1183-6. doi: 10.1128/CVI.05081-11. Epub 2011 May 25.
8
Immunity against diphtheria among children and adults in Izmir, Turkey.土耳其伊兹密尔市儿童和成人对白喉的免疫力。
Vaccine. 2011 Jun 10;29(26):4341-4. doi: 10.1016/j.vaccine.2011.04.016. Epub 2011 Apr 19.
9
External quality assessment for the determination of diphtheria antitoxin in human serum.人血清中白喉抗毒素测定的外部质量评估
Clin Vaccine Immunol. 2010 Aug;17(8):1282-90. doi: 10.1128/CVI.00096-10. Epub 2010 Jul 7.
10
A review of the international issues surrounding the availability and demand for diphtheria antitoxin for therapeutic use.国际上围绕白喉抗毒素的供应和治疗需求的相关问题综述。
Vaccine. 2009 Dec 10;28(1):14-20. doi: 10.1016/j.vaccine.2009.09.094. Epub 2009 Oct 7.